ES2125356T3 - Empleo de leflunomida para la inhibicion de interleuquina 8. - Google Patents
Empleo de leflunomida para la inhibicion de interleuquina 8.Info
- Publication number
- ES2125356T3 ES2125356T3 ES94100017T ES94100017T ES2125356T3 ES 2125356 T3 ES2125356 T3 ES 2125356T3 ES 94100017 T ES94100017 T ES 94100017T ES 94100017 T ES94100017 T ES 94100017T ES 2125356 T3 ES2125356 T3 ES 2125356T3
- Authority
- ES
- Spain
- Prior art keywords
- leflunomide
- interleukin
- inhibition
- interleukin inhibition
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000015696 Interleukins Human genes 0.000 title 1
- 108010063738 Interleukins Proteins 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 title 1
- 229960000681 leflunomide Drugs 0.000 title 1
- 102000004890 Interleukin-8 Human genes 0.000 abstract 1
- 108090001007 Interleukin-8 Proteins 0.000 abstract 1
- BXDZOYLPNAIDOC-UHFFFAOYSA-N N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]-1-[2-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]piperidine-4-carboxamide Chemical compound CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCN(CC(=O)NCCOCCOCCOCCNc4cccc5C(=O)N(C6CCC(=O)NC6=O)C(=O)c45)CC3)s2)o1 BXDZOYLPNAIDOC-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 abstract 1
- 229940096397 interleukin-8 Drugs 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Abstract
LA N 4 CARBOXAMIDA ES UN COMPUESTO ACTIVO PARA LA PREVENCION Y EL TRATAMIENTO DE ENFERMEDADES, EN LAS QUE ESTA INVOLUCRADO LA INTERLEUCINA 8. ENCUENTRA APLICACION COMO MEDICAMENTO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4300278 | 1993-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2125356T3 true ES2125356T3 (es) | 1999-03-01 |
Family
ID=6477854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94100017T Expired - Lifetime ES2125356T3 (es) | 1993-01-08 | 1994-01-03 | Empleo de leflunomida para la inhibicion de interleuquina 8. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5547971A (es) |
| EP (1) | EP0607777B1 (es) |
| JP (1) | JPH06234636A (es) |
| AT (1) | ATE174220T1 (es) |
| DE (1) | DE59407415D1 (es) |
| DK (1) | DK0607777T3 (es) |
| ES (1) | ES2125356T3 (es) |
| GR (1) | GR3029489T3 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
| US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
| US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
| US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
| US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
| US6011051A (en) * | 1996-07-31 | 2000-01-04 | Hoechst Aktiengesellschaft | Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
| ATE207065T1 (de) * | 1997-08-08 | 2001-11-15 | Aventis Pharma Gmbh | Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid |
| US7051557B2 (en) * | 2002-07-18 | 2006-05-30 | Sara Lee Corporation | Hidden band brassiere, blank and methods of making same |
| AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
| WO2022128054A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
| DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
| HU222234B1 (hu) * | 1990-05-18 | 2003-05-28 | Aventis Pharma Deutschland Gmbh. | Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására |
-
1994
- 1994-01-03 EP EP94100017A patent/EP0607777B1/de not_active Expired - Lifetime
- 1994-01-03 DE DE59407415T patent/DE59407415D1/de not_active Expired - Lifetime
- 1994-01-03 ES ES94100017T patent/ES2125356T3/es not_active Expired - Lifetime
- 1994-01-03 DK DK94100017T patent/DK0607777T3/da active
- 1994-01-03 AT AT94100017T patent/ATE174220T1/de active
- 1994-01-07 JP JP6000400A patent/JPH06234636A/ja not_active Withdrawn
-
1995
- 1995-03-28 US US08/411,848 patent/US5547971A/en not_active Expired - Lifetime
-
1999
- 1999-02-25 GR GR990400585T patent/GR3029489T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06234636A (ja) | 1994-08-23 |
| EP0607777A3 (es) | 1994-08-31 |
| EP0607777A2 (de) | 1994-07-27 |
| US5547971A (en) | 1996-08-20 |
| EP0607777B1 (de) | 1998-12-09 |
| DE59407415D1 (de) | 1999-01-21 |
| ATE174220T1 (de) | 1998-12-15 |
| GR3029489T3 (en) | 1999-05-28 |
| DK0607777T3 (da) | 1999-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2178048T3 (es) | Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis. | |
| GR3025502T3 (en) | Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals. | |
| ES2163504T3 (es) | Formas de dosificacion de liberacion controlada de azitromicina. | |
| ES2059965T3 (es) | Un procedimiento para preparar una composicion farmaceutica para el tratamiento de enfermedades inflamatorias. | |
| ES2164097T3 (es) | Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial. | |
| MX9202066A (es) | Composiciones a base de acido graso para el control de infecciones establecidas en plantas. | |
| KR960700742A (ko) | 아토피성질환 치료약(atopic disease remedy) | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| ES2159851T3 (es) | Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa. | |
| ES2171543T3 (es) | Composiciones administrables topicamente que contienen derivados del acido 3-benzoilfenilacetico para el tratamiento de trastornos inflamatorios oftalmicos. | |
| ES2157422T3 (es) | Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos. | |
| ES2125356T3 (es) | Empleo de leflunomida para la inhibicion de interleuquina 8. | |
| NZ516513A (en) | Nitric oxide donors for inducing neurogenesis | |
| ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
| SE9701161D0 (sv) | New use I | |
| ES2136252T3 (es) | Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa. | |
| ES2061989T3 (es) | Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis. | |
| PT994704E (pt) | Utilizacao de analogos do gaba tal como a gabapentina no fabrico de um medicamento para o tratamento de doencas inflamatorias | |
| PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
| MX9304185A (es) | Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina. | |
| SE0004101D0 (sv) | New use | |
| ES2100680T3 (es) | Composicion para el tratamiento del cabello. | |
| ES2106319T3 (es) | Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo. | |
| NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| ES2165233T3 (es) | Empleo de 1-fosfato de esfingosina, derivados de 1-fosfato de esfingosina y/o sus mezclas para el tratamiento de enfermedades cutaneas inflamatorias. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 607777 Country of ref document: ES |